Suven Life Sciences Ltd vs Take Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Suven Life Sciences Ltd is ₹ 261.8 as of 23 Oct 15:30 . The P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Take Solutions Ltd changed from 2.6 on March 2025 to 54.3 on March 2026 . This represents a CAGR of 357.00% over 2 years The Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 yearsThe Market Cap of Take Solutions Ltd changed from ₹ 664.96 crore on March 2021 to ₹ 586.26 crore on March 2026 . This represents a CAGR of -2.08% over 6 years The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The revenue of Take Solutions Ltd for the Jun '26 is ₹ 31.7 crore as compare to the Mar '26 revenue of ₹ 59.37 crore. This represent the decline of -46.61% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The ebitda of Take Solutions Ltd for the Jun '26 is ₹ 1.06 crore as compare to the Mar '26 ebitda of ₹ 4.36 crore. This represent the decline of -75.69% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The net profit of Take Solutions Ltd changed from ₹ -3.75 crore to ₹ 1.06 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Take Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

About Take Solutions Ltd

Take Solutions Limited was incorporated on December 20, 2000.
The Company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology.
In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise.
Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
As of March 31, 2025, TAKE Solutions Pte Ltd owned 52.90% of the Company's equity share capital and has the ability to control its operating and financial policies. In Supply Chain Management, TAKE through its subsidiaries focuses on niche engineering services, supply chain collaboration and product re-engineering.

FAQs for the comparison of Suven Life Sciences Ltd and Take Solutions Ltd

Which company has a larger market capitalization, Suven Life Sciences Ltd or Take Solutions Ltd?

Market cap of Suven Life Sciences Ltd is 7,397 Cr while Market cap of Take Solutions Ltd is 161 Cr

What are the key factors driving the stock performance of Suven Life Sciences Ltd and Take Solutions Ltd?

The stock performance of Suven Life Sciences Ltd and Take Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Suven Life Sciences Ltd and Take Solutions Ltd?

As of October 24, 2026, the Suven Life Sciences Ltd stock price is INR ₹261.8. On the other hand, Take Solutions Ltd stock price is INR ₹10.93.

How do dividend payouts of Suven Life Sciences Ltd and Take Solutions Ltd compare?

To compare the dividend payouts of Suven Life Sciences Ltd and Take Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.